NEW YORK (GenomeWeb News) - Roche Diagnostics has licensed its Melting Curve Analysis technology to Eppendorf, the companies said Tuesday.
 
The non-exclusive agreement allows Eppendorf to develop and commercialize products based on the technology, which is a technique for analyzing PCR products. The deal does not allow Eppendorf to use the IP in human and veterinary in vitro diagnostics.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.